While disturbing the PNNs in the contralateral hemisphere with pretreatment of ChABC could prevent the M1 ischemia-induced abnormal c-Fos expression, impaired neuronal activity in vivo and in vitro, and dysfunction of swallowing function, and the EA efficacy was also disappeared. The gene discussed is FOS; the disease is ischemia.